Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • luc
    Senior Member
    • Dec 2010
    • 469

    #1

    "random" enzymatic DNA fragmentation - how does it work?

    Hi All,

    almost all sequencing library preparation kit providers now offer kits promising "random" enzymatic DNA fragmentation that are not based on transposon tagmentation - adapters are ligated to the fragments afterwards.
    How can this be achieved?

    This is one of the aspects of the library prep chemistry that escapes me.

    Early protocols might have used Benzonase (e.g. Shearase?). DNAse I in combination with a second nuclease completing the double-strand break might have been used for the first NEB Fragmentase. Another option might be the use of a "balanced" cocktail of restriction enzymes?

    How can the reaction be controlled to arrive at usable fragment lengths and allow a mostly unbiased representative representation of the sample in the resulting library?

    The degree of fragmentation is for some kits clearly DNA sample concentration dependent but some providers claim their reactions are merely time-dependent (e.g. Nugen , NEB) which would be very advantageous, if true.
    Last edited by luc; 01-21-2019, 09:43 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...